Form 483

Genus Lifesciences Inc. Form 483, 2017-09-29

FDA issued a Form 483 to Genus Lifesciences Inc. on 2017-09-29 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Genus Lifesciences Inc. · Allentown, United States · Issued September 29, 2017

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Sep 2017
21 CFR 211.194(a)

Complete test data included in records

Cited by Toyin B Oladimeji

29 Sep 2017
21 CFR 211.68(b)

Computer control of master formula records

Cited by Toyin B Oladimeji

Inspected site

GLGenus Lifesciences Inc.Allentown, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.194(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 2 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere